Diligence memo · auto-generated · as of July 2, 2026
Protibea Therapeutics, Inc.
Protibea Therapeutics, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Protibea Therapeutics, Inc. operates in Pharma, based in GEORGETOWN.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Protibea Therapeutics, Inc. has raised $970K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $770K on 2021-05-10.
Most recent recorded round closed around 2025-07-30.
Valuation (modeled)modeled
Provath models Protibea Therapeutics, Inc. at approximately $481K (range $112K–$1.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.75× the median modeled value of Pre-Seed Pharma companies in 2025–2027 (8 peers) — value vs value, same stage and era. Within the normal band (75% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 51 months.
Last raise 11 mo ago; this sector typically re-raises about every 16 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 3.9× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 34% of Pharma peers (310 compared).
Modeled value ranks above 18% of those peers.
Closest niche peers: Mizar Therapeutics, Inc., ReEngage Therapeutics, Inc., King Therapeutics LLC, Dnp Therapeutics Inc, Thiogenesis Therapeutics, Corp..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.